Advertisement

Mononitrate II pp 167-177 | Cite as

Differential Effects of Nitrates and Calcium Antagonists on the Coronary Vasculature in Conscious Patients

  • C. J. Pepine
  • R. L. Feldman
  • C. R. Lambert
  • J. A. Hill
Conference paper
Part of the International Boehringer Mannheim Symposia book series (BOEHRINGER)

Abstract

Both nitrates and calcium antagonists are clearly beneficial in patients with ischemic heart disease. The precise mechanisms responsible for these favorable actions, however, are not completely understood. Both classes of drugs reduce myocardial oxygen demand and have been suggested to produce important actions on the coronary circulation [1–3]. This suggestion is based upon extensive animal experimentation and studies of patients with coronary artery spasm. But extrapolation from animal studies to patients with coronary artery disease (CAD) is always difficult and patients with coronary spasm are not the same as those with chronic effort angina in whom these agents are more frequently used. Furthermore, certain clinical situations may dictate use of a nitrate rather than a calcium antagonist or vice versa and the drugs may be used in combination. So determination of the similarities and differences of the coronary vascular effects of these agents could be of clinical importance.

Keywords

Leave Anterior Descend Aortic Pressure Left Ventricular Filling Pressure Epicardial Coronary Artery Myocardial Oxygen Demand 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pepine CJ, Conti CR (1981) Calcium blockers in coronary heart disease. Part I. Mod Concepts Cardiovasc Dis 50: 61–66PubMedGoogle Scholar
  2. 2.
    Pepine CJ, Conti CR (1981) Calcium blockers in coronary heart disease. Part II. Mod Concepts Cardiovasc Dis 50: 67–72PubMedGoogle Scholar
  3. 3.
    Hintze TH, Vatner SF (1983) Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs. Circ Res 52 (suppl I): 139–146Google Scholar
  4. 4.
    Mehta J, Pepine CJ (1978) Effect of sublingual nitroglycerin on regional flow in patients with and without coronary disease. Circulation 58: 803–807PubMedGoogle Scholar
  5. 5.
    Feldman RL, Pepine CJ, Curry RC, Conti CR (1979) Coronary arterial responses to graded doses of nitroglycerin. Am J Cardiol 43: 91–97PubMedCrossRefGoogle Scholar
  6. 6.
    Feldman RL, Marx JD, Pepine CJ, Conti CR (1982) Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation 66: 321–327PubMedCrossRefGoogle Scholar
  7. 7.
    Feldman RL, Hill JA, Conti JB, Conti CR, Pepine CJ (1983) Analysis of coronary responses to nifedipine alone and in combination with intracoronary nitroglycerin in patients with coronary artery disease. Am Heart J 105: 651–658PubMedCrossRefGoogle Scholar
  8. 8.
    Feldman RL, Day RM, Hill JA, Conti CR, Pepine CJ (1983) Comparison of the effects of nitroprusside and nitroglycerin on coronary size. Cathet Cardiovasc Diagn 9: 391–399PubMedCrossRefGoogle Scholar
  9. 9.
    Feldman RL, Joyal M, Conti CR, Pepine CJ (1984) Effect of nitroglycerin on coronary collateral flow and pressure during acute coronary occlusion. Am J Cardiol 54: 958–963PubMedCrossRefGoogle Scholar
  10. 10.
    Feldman RL, Hill JA, Conti CR, Pepine CJ (1985) Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion. J Am Coll Cardiol 5: 318–325PubMedCrossRefGoogle Scholar
  11. 11.
    Lambert CR, Hill JA, Nichols WW, Feldman RL, Pepine CJ (1985) Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol 55: 652–656PubMedCrossRefGoogle Scholar
  12. 12.
    Feldman RL, MacDonald RG, Pepine CJ (1986) Do calcium antagonists improve collateral flow during acute coronary occlusion in man (abstract)? Circulation 74 (suppl II): II-190Google Scholar
  13. 13.
    Milnor WR (1982) Hemodynamics. Williams and Wilkins, Baltimore, pp 12–17Google Scholar
  14. 14.
    Lichtlen PR, Kimura E, Taira N (ed) (1979) International Adalat panel discussion. New experimental and clinical results. Exerpta Medica, Princeton, p 94Google Scholar
  15. 15.
    Forman R, Kirk ES (1980) Comparative effects of vasodilator drugs on large and small coronary resistance vessels in the dog. Cardiovasc Res 14: 601–606PubMedCrossRefGoogle Scholar
  16. 16.
    Takeda K, Nakagawa Y, Katano Y, Imai S (1977) Effects of coronary vasodilators on large and small coronary arteries of dogs. Jpn Heart J 18: 92–101PubMedCrossRefGoogle Scholar
  17. 17.
    Hugenholtz PG, Michels HR, Serruys PW, Brower RW (1981) Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia. Am J Cardiol 47: 163–173PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • C. J. Pepine
  • R. L. Feldman
  • C. R. Lambert
  • J. A. Hill

There are no affiliations available

Personalised recommendations